Sensos Redefines Pharmaceutical Logistics with World’s First GDP-Validated Smart Label
״Sensos enables a shift from passive tracking to proactive exception management—validated, secure, and audit-ready״
Clifton, NJ – September 2025 — Sensos, the global innovator in cold chain visibility, today launched the first fully GDP-compliant cellular smart Label. Disposable, real-time, and audit-ready, the Sensos Label replaces outdated data loggers with a validated solution that ensures compliance from the first mile to the last.
As outlined in its newly released white paper, Beyond the Data Logger: The Role of GDP-Compliant Cellular Smart Labels in Pharma Logistics, Sensos’ solution addresses the growing regulatory and operational demands of the pharmaceutical supply chain with a completely validated, plug-and-play alternative to legacy data loggers.
“Pharma companies are under mounting pressure to demonstrate real-time compliance, not just post-shipment documentation,” said Aviv Castro, CEO of Sensos. “With the release of our GDP-compliant smart Label, Sensos enables a shift from passive tracking to proactive exception management – validated, secure, and audit-ready.”
Built for Compliance. Designed for Simplicity.
The Sensos smart Label is the first of its kind: a disposable, cellular-connected device that offers real-time visibility into temperature, humidity, shock, and light exposure, with immediate alerts and full audit trails.
Unlike traditional data loggers that require manual activation, data downloads, and retrospective reporting, the Sensos Label is pre-calibrated, GDP-validated, and deploys instantly, just apply and ship.
Validation Master Plan Confirms GDP Readiness
Backed by a full Validation Master Plan (VMP), Sensos has rigorously validated its Smart Label system—including hardware, firmware, APIs, and cloud services—against EU GDP guidelines, GAMP5, ISO 17025 calibration standards, and ALCOA+ data integrity principles.
Key components of the validation package include:
- IQ/OQ/PQ protocols verifying performance in real-world conditions
- Immutable audit trails and 21 CFR Part 11–aligned electronic records
- ISO 17025–certified sensor calibration
- CAPA and change control procedures to ensure lifecycle compliance
- Cloud platform validation, API integrity, and end-to-end traceability
This comprehensive framework allows pharmaceutical companies to confidently deploy Sensos devices across the globe—with no gaps in compliance and full audit support.
A Game-Changer for GDP-Sensitive Shipments
Cold chain failures cost the industry billions annually. With the Sensos smart Label, pharmaceutical and biotech companies can now:
- Receive real-time alerts during shipment—not just after
- Automate documentation for GDP inspections and partner audits
- Eliminate reverse logistics with disposable, single-use devices
- Meet global compliance standards without the need for retroactive validation
“This launch is more than a product milestone—it’s a strategic enabler for pharmaceutical companies seeking to win high-value, compliance-critical contracts,” added Meira Diskin, VP of Quality at Sensos.
Request the GDP Validation Pack or Demo
To receive the GDP Validation Pack or book a product demonstration, click the link below:
